However, it is encouraging that preclinical and early human studies suggest that GLP-1 agonism appears broadly protective: indeed clinical trials of these agents are being initiated in cardiovascular disease (SELECT and SOUL trials, see below), NASH, and neurodegeneration (Alzheimers and Parkinsons)
Contrave and Wegovy may not be right for you if you have certain medical conditions or other factors that affect your health
Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanandium, and zinc
Working closely with your healthcare provider ensures a smoother transition and supports long-term health goals
Eli Lillys Mounjaro has pushed the envelope further, showing more than 20% body mass reduction in trials and generating over $500 million in sales in its debut quarter
While this medication, like all medications, comes with potential side effects, some are more common than others